- Home
- AVNS vs DIAX Comparison
AVNS vs DIAX Comparison
Compare AVNS & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVNS | DIAX |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.7M | 561.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AVNS | DIAX |
|---|---|---|
| Price | $15.12 | $15.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 589.0K | 96.6K |
| Earning Date | 02-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.93% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $699,900,000.00 | N/A |
| Revenue This Year | $3.07 | N/A |
| Revenue Next Year | $2.16 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.70 | N/A |
| 52 Week Low | $9.30 | $12.80 |
| 52 Week High | $16.80 | $15.12 |
Technical Indicators
Market Signals| Indicator | AVNS | DIAX |
|---|---|---|
| Relative Strength Index (RSI) | 77.08 | 65.48 |
| Support Level | $12.75 | $15.22 |
| Resistance Level | $14.61 | $15.50 |
| Average True Range (ATR) | 0.47 | 0.15 |
| MACD | 0.16 | 0.02 |
| Stochastic Oscillator | 100.00 | 98.28 |
Price Performance
Historical ComparisonAbout AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.